You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
3 August 2026 - Coiled Therapeutics plc (AIM: COIL) (OTCQB: COTXF), a clinical-stage precision oncology company, announced on Monday that it has dosed the first patient in the US with an optimised lipid-based oral formulation of its Phase I cancer th...
3 August 2026 - Clinical-stage biopharmaceutical company Mezzion Pharma Co Ltd on Sunday announced positive results from a new in vivo study of udenafil, a novel phosphodiesterase type 5 (PDE5) inhibitor, in autosomal dominant polycystic kidney disea...
3 August 2026 - GlycoNex Inc (TPEx:4168), a Taiwan-based, clinical-stage biopharmaceutical company, announced on Sunday that the first participant has been successfully dosed in the First-in-Human (FIH) Phase I clinical trial of GNX1021, the company&...
31 July 2026 - Hong Kong-based biotechnology company IMPACT Therapeutics, Inc. (HKG: 7630) announced on Friday that it has entered an exclusive partnership with Pharmanovia, granting the global specialty pharmaceutical company rights to manufacture, ...
31 July 2026 - Datroway (datopotamab deruxtecan), jointly developed by Japanese healthcare company Daiichi Sankyo Co Ltd (TYO:4568) and British-Swedish biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN), has received European Un...
31 July 2026 - Karyopharm Therapeutics Inc (Nasdaq:KPTI), a commercial-stage pharmaceutical company developing novel cancer therapies, on Thursday announced topline results from its Phase 3 XPORT-EC-042 trial evaluating XPOVIO (selinexor) as a mainte...
31 July 2026 - Portugal-based Proteotype Diagnostics Unipessoal LDA on Thursday unveiled Alchemi, its proprietary data and clinical workflow platform being developed for Enlighten, the company's investigational blood-based multi-cancer test.Enli...